Tina Lisa Pinto Slottow MD FACC
Interventional Cardiology, Clinical Informatics
Inova Medical Group Cardiology
Join to View Full Profile
8505 Arlington BlvdSte 200Fairfax, VA 22031
Phone+1 703-698-8525
Dr. Slottow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
MedStar Health Georgetown UniversityFellowship, Interventional Cardiology, 2007 - 2008- MedStar Health Georgetown UniversityFellowship, Cardiovascular Disease, 2004 - 2007
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2001 - 2004
University of Michigan Medical SchoolClass of 2001
Certifications & Licensure
VA State Medical License 2008 - 2026
DC State Medical License 2004 - 2010
MA State Medical License 2003 - 2006
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
National Board of Physicians and Surgeons Cardiovascular Disease- National Board of Physicians and Surgeons Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 1 citationsClinical outcomes after implantation of small diameter (=2.5 mm) sirolimus- versus paclitaxel-eluting stents.Laurent Bonello, Ashesh N. Buch, Axel de Labriolle, Probal Roy, Daniel H. Steinberg
International Journal of Cardiology. 2010-09-24 - 44 citationsPrevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.Tina L. Pinto Slottow, Laurent Bonello, Rekha Gavini, Patricia Beauzile, Steven J Sushinsky
The American Journal of Cardiology. 2009-08-15 - 16 citationsHead-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplastyLaurent Bonello, Axel de Labriolle, Probal Roy, Daniel H. Steinberg, Tina L. Pinto Slottow
Cardiovascular Revascularization Medicine. 2009-07-01
Press Mentions
Aspirin Use: Significant Change in National Guidelines for Taking Aspirin to Prevent Heart Disease and StrokeMay 10th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
